MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Sport based approach in patients with Parkinson’s disease

    G. Peker (CABA, Argentina)

    Objective: We describe our 2-year experience implementing a sport based approach in patients with Parkinson’s Disease (PD). Background: PD is a progressive neurological disorder. The…
  • 2023 International Congress

    Expanding the reach of a telehealth psychotherapy hub to advance coordinated depression care for rural veterans with Parkinson’s Disease

    J. Mack, L. Marsh, A. Sarwar, K. Rodriguez, A. King, M. Hinojosa-Lindsey, R. Miller, L. ST. Hill, S. O'Connor, K. Ketchum, M. Latorre, A. Interian, R. Dobkin (Portland, USA)

    Objective: To describe the ongoing implementation and expansion of a telehealth psychotherapy hub to treat depression in rural Veterans with PD. Background: Depression is common…
  • 2023 International Congress

    Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease

    EC. Santiago, AJ. Hernández Medrano, MA. Ruiz Mafud, AA. Herrera Ruiz, DR. Aguilar Godinez, LG. Lira Juárez, MA. Medrano Delgado, AM. Regalado Mustafá, A. Domínguez García, G. Hernandez Armesto, DP. Romero Terán, K. Talavera Lagunas, MF. Medina-Pérez, JF. García Hernández, A. Abundes-Corona, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga (MÉXICO, Mexico)

    Objective: To describe the relation between dysphagia and body mass index and the increase in anxiety and depression in patients with parkinson’s disease. Background: Parkinson’s…
  • 2023 International Congress

    High Intensity Interval Training for people with Parkinson’s disease: individual response patterns of (non-)motor symptoms and blood-based biomarkers – a crossover single-case experimental design

    E. van Wegen, E. Amaral-Gomez, M. Rietberg, V. de Groot, M. Hirsch, T. Vanbellingen, W. Vanden Berg, O. Vanden Heuvel, C. Vriend (Amsterdam, Netherlands)

    Objective: To quantify individual response patterns of motor symptoms to alternating exercise modalities, along non-motor functioning and blood biomarkers of neuroplasticity and neurodegeneration. Background: Physical…
  • 2023 International Congress

    Selenium mitigates ferroptosis-mediated dopaminergic cell death by regulating the Nrf2/GPX4 pathway: Implication for Parkinson’s disease

    YJ. Jung, H. Choi, E. Oh (Daejeon, Republic of Korea)

    Objective: The objective of this study is to explore the protective properties of selenium in an in vitro PD model, especially focusing on its underlying…
  • 2023 International Congress

    Performance of commercial EEG wearable for sleep classification in Parkinson disease

    D. González, D. Wang, E. Pollet, A. Velarde, S. Horn, J. Ramirez-Castaneda, P. Coss, O. Vaou, J. Wang, C. Li, S. Seshadri, H. Miao, M. Gonzales (Chicago, USA)

    Objective: To evaluate the performance of a consumer-grade EEG device compared against polysomnography (PSG) in individuals with Parkinson’s disease (PD). Background: Sleep disturbance is an…
  • 2023 International Congress

    Patterns of subthalamic synchronized oscillatory activity associated with parkinsonian subtypes

    P. Zhuang, M. Hallett, H. Feng, Y. Zhang, J. Li, Y. Hu, Y. Li (Beijing, China)

    Objective: To explore whether patterns of synchronized subthalamic oscillatory neurons are involved in generating parkinsonian subtypes. Background: The pathophysiology for parkinsonian subtypes is unclear. Both…
  • 2023 International Congress

    Effects of motor and cognitive complex training on obstacle-crossing ability in participants with Parkinson’s disease

    R Y. Wang, C W. Hung, Y R. Yang (Taipei, Taiwan)

    Objective: To investigate the effects of complex walking training and motor-cognitive training on obstacle-crossing ability in Parkinson’s disease (PD). Background: Obstacle crossing needs both motor…
  • 2023 International Congress

    Rehabilitation robot-assisted gait training for Parkinson’s disease: A systematic review and meta-analysis of its effects on lower extremity dyskinesia and motor function

    M. Elfaituri, T. Khaled, A. Benghatnsh (Tripoli, Libya)

    Objective: This systematic review and meta-analysis aimed to evaluate the efficacy of RAGT in improving lower extremity dyskinesia and motor function-related indicators, including the 10-meter…
  • 2023 International Congress

    Defining neuropsychiatric symptoms fluctuations in Parkinson’s disease

    A. Trinchillo, FP. Cucinotta, A. de Angelis, I. Cociasu, M. Horne, F. Morgante, L. Ricciardi (Giugliano in Campania, Italy)

    Objective: To evaluate the demographic and clinical correlates of Parkinson’s disease (PD) patients with fluctuations of neuropsychiatric symptoms (NPS-F). Background: Clinical correlates of fluctuations of…
  • « Previous Page
  • 1
  • …
  • 203
  • 204
  • 205
  • 206
  • 207
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley